7-week Study With CT-155 in People With Schizophrenia
Completed · Not applicable
Conditions studied: Schizophrenia
In brief
CT-155 is a novel prescription digital therapeutic (PDT) to treat schizophrenia
Key facts
- Study ID
- NCT05486312
- Run by
- Click Therapeutics, Inc.
- People needed
- 72
- Starts
- 2022-07-05
- Expected to finish
- 2022-12-12
- Last updated by the study team
- 2025-05-15
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Has outpatient treatment status of schizophrenia.
- Is on a stable dose of antipsychotic medication(s)
- Is the solo user of an iPhone with iPhone operating system (iOS)13 or greater capabilities or a smart phone with an Android operating system (OS) 9 or greater capabilities.
- Is the owner of, and has regular access to, an email address.
- Has regular access to the internet via cellular data plan and/or wifi.
- Willing and able to receive SMS text messages on their smartphone and email messages, and understand how to use the downloaded Study App.
- Has stable housing and has remained at the same residence for at least 12 weeks prior to screening, with no anticipated housing changes during the duration of the study
You may not qualify if…
- Is currently treated with more than two antipsychotic medications.
- Is currently treated with clozapine or haloperidol.
- Has active prominent positive symptoms to preclude effective engagement in treatment for negative symptoms.
- Is currently receiving or has received psychotherapy within 12 weeks prior to screening.
- Meets either the International Classification of Diseases (ICD-10) or DSM-5 criteria for diagnoses not under investigation.
- Has post-traumatic stress disorder (PTSD), bipolar disorder, major depressive disorder, developmental disorders, or any prominent disorder.
- Has substance or alcohol use disorder.
- Currently needs or will likely require prohibited concomitant medications.
- Is currently participating in another clinical study.
- Prior participation in the CT-155-C-001 clinical study.
- Has suicidal ideation or behavior.
Where it is running
- CT-155 Study Center — Culver City, California, United States
- CT-155 Study Center — Garden Grove, California, United States
- CT-155 Study Center — La Habra, California, United States
- CT-155 Study Center — San Bernardino, California, United States
- CT-155 Study Center — Santa Ana, California, United States
- CT-155 Study Center — Chicago, Illinois, United States
- CT-155 Study Center — New York, New York, United States
- CT-155 study Center — Staten Island, New York, United States
- CT-155 Study Center — Beachwood, Ohio, United States
- CT-155 Study Center — Oklahoma City, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.